The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional Chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy

Chinese Journal of Lung Cancer

Volumn 11, Issue 3, 2008, Pages 441-444

  Chen, Yanzhi ^a   Di, Iijun ^a   Zhang, Shulan ^b   Chen, Maosen ^c   Sun, Hong ^a   Gao, Fei ^a   Zhang, Ying ^a   Li, Pingping ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; CISPLATIN; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHINESE MEDICINE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

EID: 47149116250     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.03.003     Document Type: Article

References (10)

1. Miller TP. Rationale for the use of chemotherapy in non-small cell lung cancer. Semi Oncol, 1990, 17(4): 11-13
2. Zhou QH, Zhang ZX. Advances of traditional Chinese medicine as anti-angiogenesis for lung cancer therapy. Chin J Lung Cancer, 2006, 9(1): 96-99.
3. Scagliotti GV, De Marinis F, Rinaldi M, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non- small-cell lung cancer. J Clin Oncol, 2002, 20(21): 4285-4291.
4. Sun Y. The pathogenisis, early preveation, early diagnosis and early treatment of lung cancer. Chin Med Trib, 2004, 30(47): 13.
5. Wozniak AJ, Crowley JJ, Balcerzak SP, et al. Randomized trial comparing cisplatin with cisplatin plus vinorebine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol, 1998, 16(7): 2459-2465.
6. Bernardo G, Cuzzoni Q, Strada MR, et al. First-line chemotherapy with vinorebine, gemcitabine and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study. Cancer Invest, 2002, 20(3): 293-320.
7. Chen YZ, Li PP, Sun H, et al. Therapeutic effect of chemotherapy scheme relying mainly on navelbine in treatment of advanced non-small-cell lung cancer. Chin J Clin Oncol, 2001, 28(4): 270-272.
8. Lin HS. Clinical research of TCM on advanced non-small cell lung cancer. In: Song SP. ed. Chinese Clinical Oncology Education Issue. Qing dao: Chinese Ocean Univercity Press, 2005. 49-56.
9. Zhou DH, Lin LZ, Zhou YQ, et al. Effect of chinese herbal medicine in prolongging median survival time in patients with non-small-cell lung cancer. J Guangzhou Univ Tradi Chin Med, 2005, 22(4): 255-257.
10. Li JH. The treatment of non-small-cell lung cancer with integrated traditional chinese medicine and western medicine improving survival. Oncol Pro. 2006, 4(6): 89-491.